IP Library › Granted Patent US 7,482,128
Granted Patent B2
US 7,482,128 · App. 10/550,563 · Granted Jan 27, 2009

Anti-feline albumin antibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,482,128
App. No.
10/550,563
Granted
Jan 27, 2009
Kind
B2
Abstract

The present invention provides isolated monoclonal antibodies that selectively bind albumin from animals. Also provided are methods using such antibodies for the detection of early renal disease in animals. The method includes the steps of (a) obtaining a sample from an animal to be tested; (b) contacting the sample with an antibody having a greater avidity for feline albumin than for other proteins or components in the sample; (c) detecting the complex formed by the antibody and albumin; and (d) determining the amount of albumin in the sample from the amount of antibody-albumin complex detected. An amount of albumin in the range of from 10 μg/ml to about 300 μg/ml indicates the presence of early renal disease.

Claims (4)

1. An isolated monoclonal antibody that selectively binds albumin from a fetid or a canid, wherein said antibody binds the same epitope recognized by the monoclonal antibody produced by the hybridoma cell line having ATCC Accession No. PTA-9498 (MAb H425).

2. A kit comprising:

(a) an isolated monoclonal antibody that selectively binds albumin from a feud or canid, wherein said antibody binds the same epitope recognized by the monoclonal antibody produced by the hybridoma cell line having ATCC Accession No. PTA-9498 (MAb H425); and

(b) a means for detecting the amount of albumin in a sample collected from a felid or canid, wherein said means detects albumin in a range from about 10 μg/ml to about 50 μg/ml.